Fournier Pharma Announces Results of the Largest Clinical Trial in Patients With Type 2 Diabetes Demonstrating Positive Effects of Fenofibrate Therapy on Cardiovascular Events
Dallas, Texas, November 14 (ots/PRNewswire) - - FIELD Confirms Fenofibrate Produces Macrovascular and Microvascular Benefits in Diabetic Patients Without Previous Cardiovascular Disease Although Primary Endpoint is not met Results of the largest intervention study ever conducted for the prevention of ...
plus